TCTR20210510009尚未招募不适用
SARS-CoV-2 Antibody responses in end-stage renal disease patients after COVID-19 Vaccination
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Age 18 years or more
- •2. End stage renal disease patients with renal replacement therapy visiting out-patient department
- •3. Eligible for COVID-19 vaccination
- •4. Informed consented for participation
排除标准
- •1. Allergy to component in COVID-19 vaccine
- •2. Diagnosed with COVID-19 infection
- •3. Contraindicated for COVID-19 vaccine
- •4. On immunosuppressant
研究者
相似试验
已完成
不适用
Robust antibody response after 3 doses of mRNA COVID-19 vaccine in hemodialysis patientshemodialysis patientsJPRN-UMIN000047083Fujita Memorial Hospital283
撤回
不适用
COVID Vaccine Immunity in Kidney Transplant RecipientsEnd Stage Renal DiseaseKidney Transplant ComplicationsNCT05387343University of Alabama at Birmingham
Unknown
不适用
Immune Response of Haemodialysis Patients Post Covid-19 VaccinationImmune Response Post Covid 19 VaccinationNCT04872751Penang Hospital, Malaysia425
已完成
不适用
Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.DialysisCovid19NCT04633915Saint Petersburg State University, Russia51
已完成
4 期
SARS-CoV-2-specific immune responses after two versus three doses COVID-19 vaccination in end-stage renal disease patients and kidney transplant recipientsCOVID-19renal transplant, immunogenicity, safety, humoral immunity, cell-mediated immunityTCTR20210524002Faculty of Medicine Ramathibodi Hospital, Mahidol University120